10-K: SRx Health Solutions Pivots to Pet Wellness Amid Restructuring

SRx Health Solutions Inc. has completed a reverse merger, discontinuing its Canadian healthcare operations to focus solely on its Halo pet health and wellness business, despite reporting significant losses.

Summary

• SRx Health Solutions Inc. (formerly Better Choice Company, Inc.) completed a reverse merger on April 24, 2025, with SRx Canada identified as the accounting acquirer.
• The company has strategically discontinued its Canadian pharmacy and healthcare services business (SRx Canada), which is now classified as discontinued operations.
• Continuing operations are focused exclusively on the premium pet health and wellness business under the Halo brand, offering foods, treats, toppers, dental products, chews, and supplements for dogs and cats.
• Net sales from continuing operations for the year ended September 30, 2025, were $6.5 million, with a gross profit of $1.5 million (23% gross margin).
• The company reported a net loss from continuing operations of $(8.6) million and a total comprehensive loss of $(47.4) million for the year ended September 30, 2025.
• SRx Canada initiated restructuring proceedings under the Companies Creditors Arrangement Act (CCAA) in August 2025 due to financial difficulties and non-compliance with loan covenants.
• The company secured $1.75 million in debtor-in-possession (DIP) financing for SRx Canada's restructuring.
• Significant capital raising activities occurred, including a July PIPE financing of $7.65 million in senior secured convertible notes and warrants, and an October PIPE financing of $15.23 million in Series A convertible preferred stock and warrants.
• An Equity Line of Credit (ELOC) agreement was amended to increase committed capital from $50 million to $1.0 billion, with a $20.0 million convertible promissory note issued as commitment consideration.
• The company's common stock market value for non-affiliates was $9,142,691 as of the most recent third fiscal quarter, with 27,426,843 shares outstanding as of December 4, 2025.

Sentiment

Score: 3

Explanation: The company is undergoing a significant and necessary restructuring, exiting a failing business segment and focusing on a smaller, more viable pet wellness operation. While the strategic pivot is a positive, the substantial historical losses, ongoing negative cash flow from continuing operations, and the bankruptcy of the former core business indicate severe financial distress. The capital raises provide short-term liquidity but also involve significant dilution and debt, reflecting a challenging financial position.

Positives

• Successful completion of a reverse merger, streamlining the business model.
• Strategic pivot to focus solely on the Halo pet health and wellness business, which has a more streamlined operating footprint and reduced overhead.
• Recognition of a bargain purchase gain of $4.1 million from the reverse merger.
• Successful capital raises through July PIPE ($7.65 million) and October PIPE ($15.23 million) financings, providing necessary liquidity.
• Amendment of the Equity Line of Credit (ELOC) to increase committed capital to $1.0 billion, indicating potential for future funding.
• Management's focus on stabilizing remaining operations, optimizing cost structure, and re-establishing a focused growth path for the Consumer Products business.
• Strong brand loyalty in the e-commerce channel for Halo products, driving repeat purchases.

Negatives

• Incurred a significant total comprehensive loss of $(47.4) million for the year ended September 30, 2025.
• Net loss from continuing operations was $(8.6) million, and loss from discontinued operations was $(36.4) million.
• Negative operating cash flow of $(8.1) million for continuing operations in 2025.
• SRx Canada, the former primary business, filed for creditor protection under the CCAA in August 2025 due to financial difficulties and non-compliance with loan covenants.
• The company was not in compliance with certain financial covenants of its Canadian Western Bank (CWB) loan facility as of June 30, 2025, making the debt callable.
• Significant increase in cash used in operating activities, up $6.7 million (451%) from the prior year.
• The company has historically incurred operating losses and experienced negative operating cash flows, raising substantial doubt about its ability to continue as a going concern (as per the 2024 auditor's report, though management states no material uncertainties for 2025).
• A full valuation allowance of $31.7 million was recorded against deferred tax assets due to uncertainty of realizing tax benefits from NOLs.
• High concentration risk with 85% of inventory purchases from three vendors and 88% of gross sales from three customers.
• The prepaid amount of $8.6 million related to a consulting agreement with Terra Nova Business Holdings Inc. was written off following the CCAA filing.

Risks

• Incurred significant losses in prior periods and potential future losses; inability to manage future expansion effectively; loss of key senior management; business plan not based on independent market studies; Board of Directors may change policies without shareholder approval.
• Need to obtain financing to continue operations and pursue strategic transactions; insufficient cash to fully implement business plan; potential for dilution from future equity or convertible securities; level of indebtedness and related covenants could limit operational and financial flexibility; common stock may be deemed a penny stock; failure to meet NYSE American continued listing requirements could result in delisting.
• Impact of damage to or interruption of information technology systems due to cyber-attacks or other circumstances beyond control; vulnerability to physical break-ins, computer viruses, programming errors, attacks by third parties.
• Increases in sourcing, manufacturing, freight, and/or warehousing costs; supply shortages; interruption in sourcing operations; reliance on a limited number of independent third-party suppliers; inability to pass along higher costs to customers.
• Failure to maintain and expand brand or product quality; negative social/digital media posts; inability to build and sustain brand equity; product liability, product recall, or personal injury issues could damage reputation; food safety and food-borne illness incidents.
• Highly competitive pet health and wellness industry; inability to compete effectively against larger competitors with greater resources; price gaps between products leading to market share erosion.
• Failure to attract new customers or retain existing ones cost-effectively; dependence on internet-based advertising; increased costs of advertising through platforms.
• Subject to extensive governmental regulation (FDA, FTC, USDA); potential enforcement actions for non-compliance; changes in government regulations and trade policies (e.g., U.S.-China trade tensions) could adversely affect sales.
• Holding company structure makes the company dependent on subsidiaries for cash flow; Delaware law and corporate documents contain anti-takeover provisions; exclusive forum provisions could limit stockholders' ability to choose judicial forum.
• Volatile common stock prices; no expectation of cash dividends in the foreseeable future; future sales of common stock or perception of sales may depress share price; potential issuance of preferred stock could adversely affect voting power or value of common stock; administrative and regulatory costs of public company compliance.

Future Outlook

The company's outlook reflects the early stages of a strategic reset, with near-term priorities focused on strengthening the financial position of the continuing pet health and wellness operations, optimizing cost structure, and re-establishing a focused growth path. Management believes the streamlined business provides a clearer path to operational stability and disciplined execution, and will continue evaluating strategic alternatives including potential partnerships and product expansion opportunities.

Management Comments

• Management is focused on stabilizing the remaining operations, preserving core customer relationships, and ensuring continuity of service while the Company transitions to a more sustainable operating model.
• Management believes that the streamlined business provides a clearer path to operational stability and disciplined execution.
• The Company will continue evaluating strategic alternatives to support the long-term viability of the business, including potential partnerships, product expansion opportunities, and targeted investments that align with the strengths of the continuing operations.
• We believe our overall relationships with our employees are positive and the strength of our team is a critical success factor in becoming the most innovative premium pet food company in the world.
• We continually focus on employee engagement and a diverse, inclusive culture in order to ensure the continued strength and well-being of our workforce.
• We operate under a Win From Anywhere culture, which is our approach to creating a flexible and entrepreneurial working environment built for long term success.

Industry Context

The company's pivot to the pet health and wellness industry aligns with increasing consumer preference for high-quality, science-based pet nutrition and a growing e-commerce penetration in the sector. This move positions SRx Health Solutions to compete with established players like Mars, Nestlé, and General Mills' Blue Buffalo, as well as specialty brands. The discontinuation of the capital-intensive specialty healthcare model reflects challenges in a highly regulated and competitive Canadian pharmacy market, which has seen significant changes in reimbursement programs and drug pricing.

Management Changes

Corporate Governance

Legal Proceedings

• SRx Canada initiated restructuring proceedings under the Companies Creditors Arrangement Act (CCAA) in August 2025.
• The company is subject to litigation and other proceedings that arise in the ordinary course of business, but management believes there are no pending lawsuits or claims that will have a material adverse effect on the business, financial condition, or yearly results of operations.

Related Party Transactions

• Outstanding convertible promissory notes held by certain Board of Directors members totaling $0.5 million as of September 30, 2025, bearing 8% interest.
• Incurred approximately $0.7 million in director fees for the fiscal year ended September 30, 2025, with $0.5 million settled in exchange for convertible notes.
• Issued an aggregate of $3.2 million in share-based compensation to directors and executive officers during the year ended September 30, 2025.
• Paid executive officers an aggregate of $1.0 million in compensation during the year ended September 30, 2025.
• Prior to the merger, SRx Canada engaged in non-interest-bearing working capital advances with its largest shareholder and entities under common control, which were forgiven in fiscal year 2024.
• Issued 2,987,477 shares of restricted common stock to certain directors, officers, employees, and former employees of the Company as performance or service-based compensation between July and September 2025.
• Issued 2,396,697 shares of restricted common stock to certain directors, officers, and employees as performance bonus compensation on August 25, 2025.
• Issued 196,000 shares of restricted common stock to certain current and former directors on September 16, 2025.
• Issued 394,780 shares of common stock to former employees and shareholders of SRx Canada (who initially received exchangeable shares) upon retraction of their exchangeable shares.

Stakeholder Impact

• Shareholders: Significant dilution from recent and potential future capital raises (PIPE financings, ELOC, increased authorized shares), substantial losses, and the delisting risk from NYSE American could negatively impact share value. The strategic pivot to pet wellness might offer long-term value if successful.
• Employees: Organizational restructuring and changes in headcount following the discontinuation of SRx Canada operations. Equity incentive plans aim to attract, retain, and motivate employees.
• Customers (Halo): Continued focus on high-quality, science-based pet nutrition products under the Halo brand, with a shift to a digital-first strategy for sales.
• Suppliers: Reliance on a limited number of co-manufacturing partners and raw material suppliers creates concentration risk.
• Creditors: SRx Canada's CCAA filing impacts creditors of the discontinued healthcare business. The company's non-compliance with CWB loan covenants led to debt being callable, though it was subsequently deconsolidated. New debt (July PIPE notes) is secured by U.S. assets.

Next Steps

• Strengthen the financial position of the continuing operations.
• Optimize cost structure.
• Re-establish a focused growth path for the Consumer Products business.
• Evaluate strategic alternatives, including potential partnerships, product expansion opportunities, and targeted investments.
• Complete the Sale Process for SRx Canada under CCAA proceedings.
• Regain compliance with NYSE American continued listing standards by July 14, 2026.
• File a registration statement with the SEC for the resale of common stock issuable from July and October PIPE financings.
• Amend the Registration Statement to register an additional $972.45 million of Common Stock under the ELOC Purchase Agreement if authorized capital increases.
• Board of Directors to determine the ratio for an additional reverse stock split.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a total comprehensive loss of $(47.4) million and negative operating cash flow. The former core business, SRx Canada, is in bankruptcy proceedings (CCAA), and the continuing pet wellness segment, while strategically focused, is still operating at a significant loss. While recent capital raises provide some liquidity, they come with substantial dilution and increased debt. The company also faces a delisting risk from NYSE American due to non-compliance with listing standards. Given the magnitude of losses, ongoing financial challenges, and high operational risks, the stock presents a high-risk investment with significant downside potential.

Keywords

Pet Health, Pet Wellness, Halo Brand, SEC Filing, 10-K, Reverse Merger, Discontinued Operations, Financial Restructuring, Capital Raise, Convertible Notes, Warrants, E-commerce, Supply Chain, Corporate Governance, Risk Factors, NYSE American, SRx Health Solutions, Better Choice Company, Animal Food, Specialty Pharmaceuticals